Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies

Overview of attention for article published in Journal of Hematology & Oncology, January 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 26 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

METHODS AND COMPOSITIONS FOR TREATING BRAIN INJURY OR NEURODEGENERATIVE DISEASE

Application WO-2020007898-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.